News

3 Key Questions For Equity Investors To Consider
Volatility is likely to remain elevated amid ongoing uncertainty about U.S. trade policy and bilateral tariff negotiations.
Investors, Be Careful When Buying New ETFs
From an ETF provider’s perspective, creating new ETFs with different risk/reward profiles solves two problems. It’s a new ...
NextEra Energy Inc. Jr. Sub. Deb. Series U
In the past Mr. Hachigian was Chairman at JELD-WEN Holding, Inc. and Non-Executive Chairman of JELD-WEN, Inc. (a subsidiary of JELD-WEN Holding, Inc.), Principal at Skykarr Capital LLC, Chairman & ...
Jackson Adds Nasdaq 100 Index Option, Offers Full Principal Protection Option in Latest Registered Index-Linked Annuity Launch
Jackson National Life Insurance Company® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Market Link Pro® III (JMLPIII) and Jackson Market Link ...
ZEEKR Intelligent Technology Holding Limited (NYSE:ZK) Shares Could Be 49% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for ZEEKR Intelligent Technology Holding is US$58.09 based on 2 Stage Free ...
Rackspace: Shifting To Higher-Margin Cloud, Amid Risks (Rating Downgrade)
After its sustained decline, Rackspace is now a penny stock, not far from the one-dollar-per-share threshold. Read why it is ...
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. in connection with its $13.5 Million Initial Public Offering
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / On May 12, 2025, Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) ("Apimeds" or the "Company"), a clinical stage biopharmaceutical company that is in t ...
How Would a Texas Stock Exchange Compete With NYSE and Nasdaq?
Find out why major financial players are betting on "Y'all Street" to challenge the NYSE and Nasdaq and what it means for ...